Skip to main content

US ClosedU.S. Closed

LGVN: Longeveron Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Longeveron Inc. is a biotechnology company currently in the clinical development stage, dedicated to pioneering cell-based therapies.

52W Range

26thpctl

Volume

0.20×avg

Market Cap

20.45MUSD

P/E Ratio

-0.7TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Longeveron Inc.

LGVNNASDAQ Capital Market·USD·Closed

Longeveron Inc.

LGVNNASDAQ·USD·Closed

$6.72

−1.18%

$6.72

−$0.08 (1.18%)

52W Range

26thpctl

Volume

0.20×avg

Mkt Cap

20.45MUSD

P/E

-0.7TTM

Div Yield

–ann